Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2024 Earnings Call Transcript

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2024 Earnings Call Transcript August 12, 2024

Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.

Operator: Greetings and welcome to the Taysha Gene Therapies Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. I...